80-2-503.5. Psychotropic medication oversight pilot program.
| (1) |
As used in this section, “psychotropic medication” means medication prescribed to affect or alter thought processes, mood, or behavior, including antipsychotic, antidepressant, anxiolytic, or behavior medication. |
Have a question?
Click here to chat with a criminal defense lawyer and protect your rights.
Terms Used In Utah Code 80-2-503.5
- Child: means , except as provided in Section 80-2-905, an individual who is under 18 years old. See Utah Code 80-1-102
- Contract: A legal written agreement that becomes binding when signed.
- Department: means the Department of Health and Human Services created in Section 26B-1-201. See Utah Code 80-1-102
- Division: means the Division of Child and Family Services created in Section 80-2-201. See Utah Code 80-2-102
- Oversight: Committee review of the activities of a Federal agency or program.
| (2) |
The division shall, through contract with the Department of Health and Human Services, establish and operate a psychotropic medication oversight pilot program for children in foster care to ensure that foster children are being prescribed psychotropic medication consistent with the foster children’s needs. |
| (3) |
The division shall establish an oversight team to manage the psychotropic medication oversight program, composed of at least the following individuals:
| (a) |
an advanced practice registered nurse, as defined in Section 58-31b-102, contracted with the Department of Health and Human Services; and |
| (b) |
a child psychiatrist. |
|
| (4) |
The oversight team shall monitor foster children:
| (a) |
six years old or younger who are being prescribed one or more psychotropic medications; and |
| (b) |
seven years old or older who are being prescribed two or more psychotropic medications. |
|
| (5) |
The oversight team shall, upon request, be given information or records related to the foster child’s health care history, including psychotropic medication history and mental and behavioral health history, from:
| (a) |
the foster child’s current or past caseworker; |
| (c) |
the foster child’s:
| (i) |
current or past health care provider; |
|
|
| (6) |
The oversight team may review and monitor the following information about a foster child:
| (a) |
the foster child’s history; |
| (b) |
the foster child’s health care, including psychotropic medication history and mental or behavioral health history; |
| (c) |
whether there are less invasive treatment options available to meet the foster child’s needs; |
| (d) |
the dosage or dosage range and appropriateness of the foster child’s psychotropic medication; |
| (e) |
the short-term or long-term risks associated with the use of the foster child’s psychotropic medication; or |
| (f) |
the reported benefits of the foster child’s psychotropic medication. |
|
| (7) |
| (a) |
The oversight team may make recommendations to the foster child’s health care providers concerning the foster child’s psychotropic medication or the foster child’s mental or behavioral health. |
| (b) |
The oversight team shall provide the recommendations made in Subsection (7)(a) to the foster child’s parent or guardian after discussing the recommendations with the foster child’s current health care providers. |
|
| (9) |
The division shall report to the Child Welfare Legislative Oversight Panel regarding the psychotropic medication oversight pilot program by October 1 of each even numbered year. |
Amended by Chapter 309, 2023 General Session
